Actual Use Trial of Atorvastatin Calcium 10 mg
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1311 participants.
Also called NCT01964326
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 1,311 participants
- Registry
-
NCT01964326
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01964326. Allocation not applicable; no masking; primary purpose treatment. Start 2013-10 (registry gives no type); primary completion 2014-12 (actual). Results posted on 2016-01-27.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Actual Use Trial of Atorvastatin Calcium 10 mg
- Condition
- Hypercholesterolemia
- Intervention (Drug)
- Atorvastatin calcium 10 mg
- Lead sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Record details
- Record id
cardio:ct-nct01964326- Content hash
303ab9ecbfe2ef8af87275b5c4c9beaffab1d83b009d7d67fb6f739748fac3b7